Comprehensive analysis of competing endogenous RNA network and potential biomarkers in alcohol-induced osteonecrosis of the femoral head

doi:10.12307/2022.666

Abstract

Abstract: BACKGROUND: Alcohol-induced osteonecrosis of the femoral head is highly correlated with alcohol consumption. However, its specific pathogenesis is still unclear and there are certain individual differences.
OBJECTIVE: To investigate the potential pathogenesis of alcohol-induced osteonecrosis of the femoral head by constructing a gene network map of alcohol-induced osteonecrosis of the femoral head.
METHODS: Three patients with alcohol-induced osteonecrosis of the femoral head and three healthy volunteers were recruited from the Second Department of Orthopedics in the First Affiliated Hospital of Guangxi University of Chinese Medicine. Differentially expressed mRNA and lncRNA were screened out through gene sequencing of peripheral blood samples, to predict the interaction targets of lncRNA-miRNA and miRNA-mRNA. The competitive endogenous RNA regulatory network was constructed using cytoscape software.
RESULTS AND CONCLUSION: Differential expression analysis identified 127 differentially expressed lncRNAs and 921 differentially expressed mRNAs from the samples of alcohol-induced osteonecrosis of the femoral head. Then, through target gene prediction, 205 miRNAs and 5 184 mRNA targets were predicted, and finally the competing endogenous RNA network containing 3 lncRNAs (SNHG3, MUC19, LINC00476), 5 miRNAs (hsa-miR-146b-5p, hsa-miR-139-5p, hsa-miR-126-3p, hsa-miR-193a-3p, hsa-miR-135a-5p), and 11 mRNAs (PEX5, ACTR3B, CHMP4B, CSMD1, MTRF1, ZNF3, HTR7, NR5A2, SYT14, CASK, ING5) was constructed, involved in stem cell differentiation, inflammatory response, neuroendocrine, gene polymorphism, and other biological processes. To conclude, a series of potential biomarkers of alcohol-induced osteonecrosis of the femoral head have been screened out by constructing the competing endogenous RNA network, which provides new ideas for further research on its molecular mechanism and therapeutic targets.

Key words: alcohol-induced osteonecrosis of the femoral head, competing endogenous RNA network, lncRNA, mRNA, miRNA, biomarker

CLC Number:

Qian Xiaofen, Zeng Ping, Liu Jinfu, Chen Cai, Fan Siqi, Nong Jiao, Deng Wei. Comprehensive analysis of competing endogenous RNA network and potential biomarkers in alcohol-induced osteonecrosis of the femoral head[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(23): 3670-3675.

Figures/Tables 7

References

[1] HONG G, HAN X, HE W, et al. Analysis of circulating microRNAs aberrantly expressed in alcohol-induced osteonecrosis of femoral head. Sci Rep. 2019;9(1): 18926.
[2] ZHANG W, DONG R, DIAO S, et al. Differential long noncoding RNA/mRNA expression profiling and functional network analysis during osteogenic differentiation of human bone marrow mesenchymal stem cells. Stem Cell Res Ther. 2017;8(1):30.
[3] LI Z, SHEN J, CHAN MT, et al. MicroRNA-379 suppresses osteosarcoma progression by targeting PDK1. J Cell Mol Med. 2017;21(2):315-323.
[4] HAN N, LI Z. Non-coding RNA Identification in Osteonecrosis of the Femoral Head Using Competitive Endogenous RNA Network Analysis. Orthop Surg. 2021; 13(3):1067-1076.
[5] LANZILLOTTI C, DE MATTEI M, MAZZIOTTA C, et al. Long Non-coding RNAs and MicroRNAs Interplay in Osteogenic Differentiation of Mesenchymal Stem Cells. Front Cell Dev Biol. 2021:646032.
[6] 中国成人股骨头坏死临床诊疗指南(2020)[J].中华骨科杂志,2020,40(20): 1365-1376.
[7] GAO L, ZHAO Y, MA X, et al. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network and the potential prognosis indicators in sarcomas. BMC Med Genomics. 2021;14(1):67.
[8] WANG A, REN M, WANG J. The pathogenesis of steroid-induced osteonecrosis of the femoral head: A systematic review of the literature. Gene. 2018;671:103-109.
[9] ZHOU W, QU M, LV Y, et al. New Advances in Stem Cell Therapy for Osteonecrosis of the Femoral Head. Curr Stem Cell Res Ther. 2019;14(3):226-229.
[10] XU Y, JIANG Y, XIA C, et al. Stem cell therapy for osteonecrosis of femoral head: Opportunities and challenges. Regen Ther. 2020;15:295-304.
[11] BAI H, CHEN T, LU Q, et al. Gene expression profiling of the bone trabecula in patients with osteonecrosis of the femoral head by RNA sequencing. J Biochem. 2019;166(6):475-484.
[12] GANGULI G, PATTANAIK KP, JAGADEB M, et al. Mycobacterium tuberculosis Rv3034c regulates mTORC1 and PPAR-γ dependant pexophagy mechanism to control redox levels in macrophages. Cell Microbiol. 2020;22(9):e13214.
[13] HERBST S, CAMPBELL P, HARVEY J, et al. LRRK2 activation controls the repair of damaged endomembranes in macrophages. EMBO J. 2020;39(18):e104494.
[14] YUAN L, LI W, TIAN ZB, et al. Predictive role of cytokines IL-10, IL-12 and TNF-α gene polymorphisms for the development of osteonecrosis of the femoral head in the Chinese Han population. Cell Mol Biol (Noisy-le-grand). 2017;63(9):144-149.
[15] ZHAO P, LI C, CHEN B, et al. Up-regulation of CHMP4B alleviates microglial necroptosis induced by traumatic brain injury. J Cell Mol Med. 2020;24(15):8466-8479.
[16] LIU M, DING H, WANG H, et al. Moringa oleifera leaf extracts protect BMSC osteogenic induction following peroxidative damage by activating the PI3K/Akt/Foxo1 pathway. J Orthop Surg Res. 2021;16(1):150.
[17] ZHANG Q, ZHAO S, PANG X, et al. MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma. Oncol Rep. 2016;35(3):1831-1840.
[18] TIAN C, LI J, REN L, et al. MicroRNA-381 serves as a prognostic factor and inhibits migration and invasion in non-small cell lung cancer by targeting LRH-1. Oncol Rep. 2017;38(5):3071-3077.
[19] WANG Y, SUN S, XU J, et al. MicroRNA-381 suppresses the proliferation of osteosarcoma cells through LRH-1/Wnt/β-catenin signaling pathway. Oncol Rep. 2018;39(2):589-596.
[20] XU P, OOSTERVEER MH, STEIN S, et al. LRH-1-dependent programming of mitochondrial glutamine processing drives liver cancer. Genes Dev. 2016;30(11): 1255-1260.
[21] BAYRER JR, WANG H, NATTIV R, et al. LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival. Nat Commun. 2018;9(1):4055.
[22] RIANCHO JA, LIU Y, SAINZ J, et al. Nuclear receptor NR5A2 and bone: gene expression and association with bone mineral density. Eur J Endocrinol. 2012; 166(1):69-75.
[23] SCHWADERER J, PHAN TS, GLÖCKNER A, et al. Pharmacological LRH-1/Nr5a2 inhibition limits pro-inflammatory cytokine production in macrophages and associated experimental hepatitis. Cell Death Dis. 2020;11(2):154.
[24] SHENG X, LIU W, LU Z, et al. HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activation. Ann Transl Med. 2021;9(10):840.
[25] WEI YB, MCCARTHY M, REN H, et al. A functional variant in the serotonin receptor 7 gene (HTR7), rs7905446, is associated with good response to SSRIs in bipolar and unipolar depression. Mol Psychiatry. 2020;25(6):1312-1322.
[26] DOMÍNGUEZ-SOTO Á, USATEGUI A, CASAS-ENGEL ML, et al. Serotonin drives the acquisition of a profibrotic and anti-inflammatory gene profile through the 5-HT7R-PKA signaling axis. Sci Rep. 2017;7(1):14761.
[27] YEUNG EW, CRAGGS JG, GIZER IR. Comorbidity of Alcohol Use Disorder and Chronic Pain: Genetic Influences on Brain Reward and Stress Systems. Alcohol Clin Exp Res. 2017;41(11):1831-1848.
[28] BOSE P, THAKUR S, THALAPPILLY S, et al. ING1 induces apoptosis through direct effects at the mitochondria. Cell Death Dis. 2013;4(9):e788.
[29] LIU XL, MENG J, ZHANG XT, et al. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway. Thorac Cancer. 2019;10(4):848-855.
[30] DANTAS A, AL SHUEILI B, YANG Y, et al. Biological Functions of the ING Proteins. Cancers (Basel). 2019;11(11):1817.
[31] GAO W, HAN J. Overexpression of ING5 inhibits HGF-induced proliferation, invasion and EMT in thyroid cancer cells via regulation of the c-Met/PI3K/Akt signaling pathway. Biomed Pharmacother. 2018;98:265-270.
[32] ZHANG GJ, ZHAO J, JIANG ML, et al. ING5 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through regulation of the Akt/NF-κB/MMP-9 signaling pathway. Biochem Biophys Res Commun. 2018;496(2):387-393.
[33] ZHANG X, XU ZH, XIE H, et al. ING5 is a Potential Target for Osteosarcoma Therapy. Technol Cancer Res Treat. 2018;17:1533033818762680.
[34] WANG J, HUANG W, WU Y, et al. MicroRNA-193 pro-proliferation effects for bone mesenchymal stem cells after low-level laser irradiation treatment through inhibitor of growth family, member 5. Stem Cells Dev. 2012;21(13):2508-2519.
[35] CUI S, LIAO X, YE C, et al. ING5 suppresses breast cancer progression and is regulated by miR-24. Mol Cancer. 2017;16(1):89.
[36] YANG MF, LONG XX, HU HS, et al. Comprehensive analysis on the expression profile and prognostic values of Synaptotagmins (SYTs) family members and their methylation levels in gastric cancer. Bioengineered. 2021;12(1):3550-3565.
[37] QUINTERO-RIVERA F, CHAN A, DONOVAN DJ, et al. Disruption of a synaptotagmin (SYT14) associated with neurodevelopmental abnormalities. Am J Med Genet A. 2007;143A(6):558-563.
[38] ZHANG W, LIU Q, ZHAO J, et al. Long Noncoding RNA AATBC Promotes the Proliferation and Migration of Prostate Cancer Cell Through miR-1245b-5p/CASK Axis. Cancer Manag Res. 2021;13:5091-5100.
[39] DING B, BAO C, JIN L, et al. CASK Silence Overcomes Sorafenib Resistance of Hepatocellular Carcinoma Through Activating Apoptosis and Autophagic Cell Death. Front Oncol. 2021;11:681683.
[40] WANG TY, LIU XJ, XIE JY, et al. Cask methylation involved in the injury of insulin secretion function caused by interleukin1-β. J Cell Mol Med. 2020;24(24):14247-14256.
[41] VALLE-GARCÍA D, QADEER ZA, MCHUGH DS, et al. ATRX binds to atypical chromatin domains at the 3’ exons of zinc finger genes to preserve H3K9me3 enrichment. Epigenetics. 2016;11(6):398-414.
[42] ZHANG J, ZHANG C, CAO P, et al. A zinc finger protein gene signature enables bladder cancer treatment stratification. Aging (Albany NY). 2021;13(9):13023-13038.
[43] BURGESS SJ, GIBBS H, TOOMES C, et al. The Role of Csmd1 during Mammary Gland Development. Genes (Basel). 2021;12(2):162.
[44] DUARTE I, NABUURS SB, MAGNO R, et al. Evolution and diversification of the organellar release factor family. Mol Biol Evol. 2012;29(11):3497-512.
[45] LIND C, SUND J, AQVIST J. Codon-reading specificities of mitochondrial release factors and translation termination at non-standard stop codons. Nat Commun. 2013;4:2940.
[46] YU C, ZHANG F. LncRNA AC009022.1 enhances colorectal cancer cells proliferation, migration, and invasion by promoting ACTR3B expression via suppressing miR-497-5p. J Cell Biochem. 2020;121(2):1934-1944.